Human lymphocyte antigen B-associated transcript 2, 3, and 5 polymorphisms and haplotypes are associated with susceptibility of Kawasaki disease and coronary artery aneurysm

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 4, 2010, Pages 262-268

  Hsieh, Yao Yuan ^a,b   Lin, Ying Ju ^a,c   Chang, Chi Chen ^b   Chen, Da Yuan ^c   Hsu, Chin Mu ^c   Lo, Ming Min ^d   Hsu, Kung Hao ^b,e   Tsai, Fuu Jen ^a,c,e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Hsieh Yao Yuan Womens' Hospital   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHAOYANG UNIVERSITY OF TECHNOLOGY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

Author keywords

Coronary artery aneurysm; HLA; Human lymphocyte antigen; Kawasaki disease; Polymorphism

Indexed keywords

BIOLOGICAL MARKER; GENOMIC DNA; HLA B ANTIGEN;

ARTICLE; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; ECHOCARDIOGRAPHY; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN LYMPHOCYTE ANTIGEN B ASSOCIATED TRANSCRIPT 2 GENE; HUMAN LYMPHOCYTE ANTIGEN B ASSOCIATED TRANSCRIPT 3 GENE; HUMAN LYMPHOCYTE ANTIGEN B ASSOCIATED TRANSCRIPT 5 GENE; IMMUNOPATHOGENESIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 6; CORONARY ANEURYSM; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-B ANTIGENS; HUMANS; MALE; MOLECULAR CHAPERONES; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS;

EID: 77955639059     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20409     Document Type: Article

References (28)

1. Kamizono S, Yamada A, Higuchi T, Kato H, Itoh K. Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease. Pediatr Int 1999;41:341-345. (Pubitemid 29376971)
2. Leung DY, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 1989;2:1298-1302. (Pubitemid 20005671)
3. Danese S, Dejana E, Fiocchi C. Immune regulation by microvascular endothelial cells: Directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 2007;178:6017-6022. (Pubitemid 46717378)
4. Pay S, Simsek I, Erdem H, Dinc A. Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells. Rheumatol Int 2007;27:417-424. (Pubitemid 46294993)
5. Coupel S, Moreau A, Hamidou M, Horejsi V, Soulillou JP, Charreau B. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007;109:2806-2814. (Pubitemid 46482075)
6. Huang Y, Lee YJ, Chen MR, et al. Polymorphism of transmembrane region of MICA gene and Kawasaki disease. Exp Clin Immunogenet 2000;17:130-137. (Pubitemid 30481302)
7. Akagi T, Rose V, Benson LN, Newman A, Freedom RM. Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 1992;121:689-694.
8. Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005;102:4134-4139.
9. Ricci E, Malacrida S, Zanchetta M, Montagna M, Giaquinto C, De Rossi A. Role of beta-defensin-1 polymorphisms in mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 2009;51:13-19.
10. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004;364:533-544.
11. Tse SM, Silverman ED, McCrindle BW, Yeung RS. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr 2002;140:450-455. (Pubitemid 34494318)
12. Lin YJ, Wan L, Wu JY, et al. HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms. Arthritis Rheum 2009;60:604-610.
13. Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr 1992;121:924-926.
14. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-1385.
15. Muta H, Ishii M, Egami K, et al. Early intravenous gammaglobulin treatment for Kawasaki disease: The nationwide surveys in Japan. J Pediatr 2004;144:496-499. (Pubitemid 38457354)
16. Oh JH, Han JW, Lee SJ, et al. Polymorphisms of human leukocyte antigen genes in korean children with Kawasaki disease. Pediatr Cardiol 2008;29:402-408.
17. Kim JJ, Hong SJ, Hong YM, et al. Genetic variants in the HLA-G region are associated with Kawasaki disease. Hum Immunol 2008;69:867-871.
18. Barron KS, Silverman ED, Gonzales JC, St Clair M, Anderson K, Reveille JD. Major histocompatibility complex class II alleles in Kawasaki syndrome - lack of consistent correlation with disease or cardiac involvement. J Rheumatol 1992;19:1790-1793.
19. Gnjec A, D'Costa KJ, Laws SM, et al. Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease. J Neuroinflammation 2008;5:36.
20. Ramasawmy R, Cunha-Neto E, Fae KC, et al. BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy. J Infect Dis 2006;193:1394-1399. (Pubitemid 43673387)
21. Diakite M, Clark TG, Auburn S, et al. A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility. Hum Genet 2009;125:105-109.
22. Migita O, Noguchi E, Koga M, et al. Haplotype analysis of a 100 kb region spanning TNF-LTA identifies a polymorphism in the LTA promoter region that is associated with atopic asthma susceptibility in Japan. Clin Exp Allergy 2005;35:790-796. (Pubitemid 40961353)
23. Martinez A, Salido M, Bonilla G, et al. Association of the major histocompatibility complex with response to infliximab therapy in rheumatoid arthritis patients. Arthritis Rheum 2004;50:1077-1082. (Pubitemid 38480817)
24. Kwak JH, Kim SI, Kim JK, Choi ME. BAT3 interacts with transforming growth factor-beta (TGF-beta) receptors and enhances TGF-beta1-induced type I collagen expression in mesangial cells. J Biol Chem 2008;283:19816-19825.
25. Simhadri VR, Reiners KS, Hansen HP, et al. Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS ONE 2008;3:e3377.
26. Pogge von Strandmann E, Simhadri VR, von Tresckow B, et al. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 2007;27:965-974. (Pubitemid 350251218)
27. Sasaki T, Gan EC, Wakeham A, Kornbluth S, Mak TW, Okada H. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev 2007;21:848-861. (Pubitemid 46572363)
28. Kwok PY, Gu Z. Single nucleotide polymorphism libraries: Why and how are we building them? Mol Med Today 1999;5:538-543.